bairdcapital.com
Baird Capital Announces Close of $185M Venture Capital Fund IV | Baird
http://bairdcapital.com/baird-capital-announces-close-of-venture-fund-iv
PREVIEW MODE ( cancel. Baird Capital Announces Close of $185M Venture Capital Fund IV. CHICAGO, Nov. 18, 2014. Ndash; Baird Capital. Ldquo;With our experienced team and disciplined investment strategy, we will continue striving to generate strong returns for our investors,” said Gordon Pan, Managing Partner of Baird Capital. “We are very happy to have the continued support of our existing investors as well as the backing of many new limited partners.”. Sectors. Committing $10 million to $15 million i...
arboretumvc.com
Portfolio | Arboretum Ventures
http://www.arboretumvc.com/portfolio
Http:/ www.arboretumvc.com/wp/wp-content/themes/zap-installable/. Http:/ www.arboretumvc.com/. Our expertise in operations, business strategy, and investing is key to ensuring the success of the fund. As active investors, Arboretum believes in working with our portfolio. Companies outside the boardroom as well as inside it. Is a commercialization partner for medical products seeking a presence in Latin America. Provides remote ICU services to community hospitals. Is developing a minimally invasive treatm...
rwbaird.com
Baird Capital Announces Close of $185M Venture Capital Fund IV | Baird
http://www.rwbaird.com/baird-capital-announces-close-of-venture-fund-iv
PREVIEW MODE ( cancel. Skip to primary content. Great outcomes. Done well. Like Us on Facebook. Follow Us on Twitter. Join Us on LinkedIn. Join Us on Google. Watch Us on YouTube. Watch Us on Vimeo. Find a Financial Advisor. Baird Capital Announces Close of $185M Venture Capital Fund IV. CHICAGO, Nov. 18, 2014. Ndash; Baird Capital. Baird Capital’s Venture Capital team is led by Pan and Investment Partners Michael Liang, Ph.D., Jim Pavlik, Benedict Rocchio and Principal Nicole Walker, as wel...Sectors....
ventureinvestors.com
Portfolio Companies – Venture Investors
http://www.ventureinvestors.com/portfolio-companies
Feature some of the leading technology innovators in the Midwest. We are proud to work closely with our technical founders and executive teams as they bring their technologies to market. Cellectar Biosciences, Inc. Aerpio Therapeutics is a pharmaceutical company spun out of Akebia Therapeutics, with programs focused on Tie2 activation for the treatment of retinopathy, vascular leak, cancer, inflammatory bowel disease and would healing. Cellectar Biosciences, Inc. Elucent Medical is a medical device compa...
